Many drugs used to treat autism target specific symptoms, such as hyperactivity and
aggressiveness. Few drugs target the core autistic symptoms of impaired social interaction
and communication. This study will evaluate two forms of the drug secretin for the treatment
of core autistic symptoms.
Phase:
Phase 3
Details
Lead Sponsor:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator:
National Institute on Deafness and Other Communication Disorders (NIDCD)